National International Holding Co. Addresses Unusual Trading Activity

In a recent disclosure to the Dubai Financial Market, National International Holding Company (NIH), a prominent Kuwaiti shareholding company, addressed the unusual trading activity observed in its stock. The company confirmed that there have been no recent developments that could have impacted its stock price or trading volumes significantly. This statement, dated March 24, 2025, comes in response to market speculation following a noticeable increase in both price and volume as of March 23, 2025.

NIH, established in 1979 and listed on the Kuwait Stock Exchange since 2005, has a diverse investment portfolio spanning industrial, real estate, educational, technological, and various other sectors across Kuwait, the Gulf, and international markets. This diversification strategy has been a cornerstone of its investment policy, allowing the company to mitigate risks and capitalize on opportunities across different regions and industries.

The recent spike in trading activity has caught the attention of investors and analysts alike, prompting NIH to clarify its position. Mamdouh A. EL Sherbiny, CEO & Board Member of NIH, emphasized that the company has not experienced any internal changes or developments that would justify the observed trading patterns. This transparency is crucial in maintaining investor confidence and ensuring that market participants have accurate information.

Despite the unusual trading activity, NIH remains a stable entity with a robust investment strategy. The company's commitment to transparency and its diversified portfolio position it well for future growth. However, given the current circumstances and the lack of new developments from NIH, investors may consider adopting a 'hold' strategy for now. This approach allows them to monitor the situation closely while maintaining their positions in anticipation of any future announcements or market movements.

In conclusion, while the recent trading activity has raised questions, NIH's proactive communication with the market is a positive sign of its commitment to transparency and investor relations. As the situation develops, investors should stay informed and evaluate their positions based on any new information that may emerge.